Little wonder that 37% of life science executives now identify building “resilient and adaptable supply chains” as a top priority entering 2025. The key to this resilience? Increasingly, it’s strategic partnerships.
Pharma Supply Chain 2.0: Embracing Automation and Digitalization to Boost Agility in 2025
Pharma Supply Chain 2.0 refers to this next-generation supply chain – one that embraces process automation and end-to-end digitalization (beyond just AI hype) to boost agility, responsiveness, and efficiency.
Beyond the Cold Chain: Adapting Pharma Supply Chains for Next-Gen Therapies in 2025
Explore how pharma supply chains are adapting beyond traditional cold chain logistics to effectively deliver next-gen therapies like personalized medicines and biologics in 2025.
Automation & Robotics for an Autonomous Supply Chain
Discover how automation and robotics are transforming supply chains into autonomous operations, boosting efficiency, resilience, and agility across industries.
The Consolidation Wave in Pharma Supply Chains: What 2025’s Mega-Deals Mean for the Industry
Explore how 2025's pharma supply chain mega-deals reshape industry dynamics, drive efficiency, and impact global pharmaceutical logistics and compliance strategies.